Company Overview

Company name: Pharmaceutical cannabinoids research JV (Alamo CBD/Vyripharm Enterprises)
Description: Provider of pharmaceutical cannabinoids research services intended to provide pure medical cannabis oil. The company’s pharmaceutical cannabinoids research enables the businesses to provide specific chemical profiles needed for Vyripharm’s research and patient treatments.
Year founded: 2017
Parent company:
Industry: Healthcare | Group: Pharmaceuticals and Biotechnology | Code:
State: Texas
Country: United States
Region: Americas

Financial Highlights

Start up capital raised (USD Million):
Business status: Startup
Ownership: Privately Held (backing)
Revenue (USD Million):
Gross profit (USD Million):
Net income (USD Million)
Enterprise value:
Earnings before interest, tax, depreciation and amortization (EBITDA):
Fiscal period:
Financing Status: The company was formed as a joint venture between Alamo CBD and Vyripharm Biopharmaceuticals on January 3, 2017.
Number of active investors:
Profile last updated: 08-Sep-2018
Last known valuation:
Last known valuation date: